gip/glp-1 receptor agonist drugs GLP1-GIP co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica Dual GLP-1/GIP receptor agonists mechanism

22, 2025, when the U.S Food and Drug Administration (FDA) approved oral Wegovy by Novo Nordisk as the first daily, oral GLP-1 pill for weight management.

CivicScience offers insights into the impact of cost, side effects & trends in GLP-1 usage.

Read Dr

Drug interactions dont come to the top of my mind when I see GLP-1 agonists in use

GLP-1 and its synthetic analogs have emerged as significant therapeutic agents for the management of metabolic disorders, merging glycemic control with weight loss through innovative structural and delivery breakthroughs

How GLP-1 and GIP pathways work, why dual-action tirzepatide (Mounjaro) differs from GLP-1-only medicines, and what trial averages mean for UK patients.